Pneumococcal meningitis in children:: relationship of antibiotic resistance to clinical characteristics and outcomes

被引:24
作者
Buckingham, SC
McCullers, JA
Luján-Zilbermann, J
Knapp, KM
Orman, KL
English, BK
机构
[1] Bonheur Childrens Med Ctr, Memphis, TN 38103 USA
[2] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Knoxville, TN USA
[3] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA
关键词
Streptococcus pneumoniae; meningitis; antibiotic resistance; penicillin; cefotaxime; vancomycin; dexamethasone; steroids;
D O I
10.1097/00006454-200109000-00003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The relationship of antibiotic susceptibility to clinical outcome in children with pneumococcal meningitis is uncertain. Previous studies have been limited by inclusion of relatively few patients infected with nonsusceptible pneumococci and inconsistent use of empiric vancomycin. Methods. Medical records of 86 children with culture-confirmed pneumococcal meningitis at a single institution from October, 1991, to October, 1999, were retrospectively reviewed, and differences in presentation and outcome based on antibiotic susceptibility of pneumococcal isolates were assessed. Results. Of 86 isolates 34 were nonsusceptible to penicillin (12 resistant). Of 60 isolates for which cefotaxime susceptibility data were available, 17 were nonsusceptible (12 resistant). Antibiotic susceptibility was not significantly associated with death, intensive care unit admission, mechanical ventilation, focal neurologic deficits, seizures, secondary fever, abnormal neuroimaging studies or hospital days. Children with penicillin-resistant isolates had significantly higher median blood leukocyte counts (24 100/mul vs. 15 700/mul, P = 0.03) and lower median CSF protein concentrations (85 mg/dl vs. 219 mg/dl, P = 0.04), were more likely to have a CSF glucose concentration of greater than or equal to 50 mg/dl (7 of 11 vs. 15 of 68, P = 0.009) and had lower rates of sensorineural hearing loss (1 of 8 vs. 25 of 40, P = 0.02) than children with isolates that were not resistant to penicillin. Children with cefotaxime-nonsusceptible isolates had an increased median duration of primary fever compared with those with nonsusceptible strains (6 days vs. 3.5 days, P = 0.02). Conclusions. In children with pneumococcal meningitis, penicillin resistance was associated with a reduced risk of hearing loss, while cefotaxime resistance was associated with a longer duration of fever. Other outcome measures were not significantly influenced by the antibiotic susceptibility of pneumococcal isolates.
引用
收藏
页码:837 / 843
页数:7
相关论文
共 22 条
  • [1] Three-year multicenter surveillance of pneumococcal meningitis in children: Clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use
    Arditi, M
    Mason, EO
    Bradley, JS
    Tan, TQ
    Barson, WJ
    Schutze, GE
    Wald, ER
    Givner, LB
    Kim, KS
    Yogev, R
    Kaplan, SL
    [J]. PEDIATRICS, 1998, 102 (05) : 1087 - 1097
  • [2] Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee
    Arnold, KE
    Leggiadro, RJ
    Breiman, RF
    Lipman, HB
    Schwartz, B
    Appleton, MA
    Cleveland, KO
    Szeto, HC
    Hill, BC
    Tenover, FC
    Elliot, JA
    Facklam, RR
    [J]. JOURNAL OF PEDIATRICS, 1996, 128 (06) : 757 - 764
  • [3] BRADLEY JS, 1991, PEDIATR INFECT DIS J, V10, P871
  • [4] EMERGENCE OF DRUG-RESISTANT PNEUMOCOCCAL INFECTIONS IN THE UNITED-STATES
    BREIMAN, RF
    BUTLER, JC
    TENOVER, FC
    ELLIOTT, JA
    FACKLAM, RR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (23): : 1831 - 1835
  • [5] FAILURE OF CEFOTAXIME IN THE TREATMENT OF MENINGITIS DUE TO RELATIVELY RESISTANT STREPTOCOCCUS-PNEUMONIAE
    CATALAN, MJ
    FERNANDEZ, JM
    VAZQUEZ, A
    DESEIJAS, EV
    SUAREZ, A
    DEQUIROS, JCLB
    [J]. CLINICAL INFECTIOUS DISEASES, 1994, 18 (05) : 766 - 769
  • [6] Clinical outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean children
    Choi, EH
    Lee, HJ
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 26 (06) : 1346 - 1354
  • [7] Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997-98
    Doern, GV
    Brueggemann, AB
    Huynh, H
    Wingert, E
    Rhomberg, P
    [J]. EMERGING INFECTIOUS DISEASES, 1999, 5 (06) : 757 - 765
  • [8] Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance
    Fiore, AE
    Moroney, JF
    Farley, MM
    Harrison, LH
    Patterson, JE
    Jorgensen, JH
    Cetron, M
    Kolczak, MS
    Breiman, RF
    Schuchat, A
    [J]. CLINICAL INFECTIOUS DISEASES, 2000, 30 (01) : 71 - 77
  • [9] DILEMMAS IN DIAGNOSIS AND MANAGEMENT OF CEPHALOSPORIN-RESISTANT STREPTOCOCCUS-PNEUMONIAE MENINGITIS
    FRIEDLAND, IR
    SHELTON, S
    PARIS, M
    RINDERKNECHT, S
    EHRETT, S
    KRISHER, K
    MCCRACKEN, GH
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (03) : 196 - 200
  • [10] TREATMENT FAILURE WITH USE OF A 3RD-GENERATION CEPHALOSPORIN FOR PENICILLIN-RESISTANT PNEUMOCOCCAL MENINGITIS - CASE-REPORT AND REVIEW
    JOHN, CC
    [J]. CLINICAL INFECTIOUS DISEASES, 1994, 18 (02) : 188 - 193